Evidence map›Paper›PMID 11997503›Full record

ArticleMolecular and cellular biology2002

The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Xiaolin Li, Donald P McDonnell

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.American journal of clinical and experimental urology · 2014
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xiaolin LiDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Donald P McDonnell
Duke Medical Center · USDuke University Hospital · US

Funding

GENETIC DISSECTION OF PROGESTERONE RECEPTOR FUNCTIONR01DK050494 · NIDDK · DUKE UNIVERSITY · PI MCDONNELL, DONALD P · 1995 to 2004
$1.4M
NIDDK NIH HHS DK50494NIDDK NIH HHS R01 DK050494
6 · The paper itself

Abstract

The B-Myb transcription factor has been implicated in coordinating the expression of genes involved in cell cycle regulation. Although it is expressed in a ubiquitous manner, its transcriptional activity is repressed until the G(1)-S phase of the cell cycle by an unknown mechanism. In this study we used biochemical and cell-based assays to demonstrate that the nuclear receptor corepressors N-CoR and SMRT interact with B-Myb. The significance of these B-Myb-corepressor interactions was confirmed by the finding that B-Myb mutants, which were unable to bind N-CoR, exhibited constitutive transcriptional activity. It has been shown previously that phosphorylation of B-Myb by cdk2/cyclin A enhances its transcriptional activity. We have now determined that phosphorylation by cdk2/cyclin A blocks the interaction between B-Myb and N-CoR and that mutation of the corepressor binding site within B-Myb bypasses the requirement for this phosphorylation event. Cumulatively, these findings suggest that the nuclear corepressors N-CoR and SMRT serve a previously unappreciated role as regulators of B-Myb transcriptional activity.

Indexed as

CDC2-CDC28 KinasesCell Cycle ProteinsAnimalsCell LineCyclin ACyclin-Dependent Kinase 2Cyclin-Dependent KinasesDNA-Binding ProteinsMembrane ProteinsMiceModels, BiologicalMutationNuclear ProteinsNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2PhosphoproteinsCDC2-CDC28 KinasesCdk2 protein, mouseCell Cycle ProteinsCyclin ACyclin-Dependent Kinase 2Cyclin-Dependent KinasesDNA-Binding ProteinsMembrane ProteinsMybl2 protein, mouseNcor1 protein, mouseNcor2 protein, mouseNuclear ProteinsNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2Pag1 protein, mousePhosphoproteinsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-mybRecombinant Fusion ProteinsRepressor ProteinsTrans-Activators

Identifiers

PMID11997503
PMCPMC133817
OpenAlexW2116537012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.